Galderma Group AG (FRA:PY30) Other Income (Expense) : €-32 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Other Income (Expense)?

Galderma Group AG's other income expense for the Galderma Group AG's pretax income for the six months ended in Dec. 2024 was €-7 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-32 Mil.

Galderma Group AG Other Income (Expense) Historical Data

The historical data trend for Galderma Group AG's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Other Income (Expense) Chart

Galderma Group AG Annual Data

Trend

Dec23

Dec24

Other Income (Expense)

-67.86

-32.47

Galderma Group AG Semi-Annual Data
	Jun23	Dec23	Jun24	Dec24
Other Income (Expense)	-34.15	-33.93	-25.08	-6.69

Galderma Group AG Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-32 Mil.

Galderma Group AG (FRA:PY30) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (FRA:PY30) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

GALDY:USA GDERF:USA GALDz:UK GALD:Switzerland

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines